CLINICAL_TRIALS
trial_result
· 2014-02-04
Clinical Trial Update: A Switch-Over Study of the Safety and Efficacy of ISU302 in Patients With Type 1 Gaucher Disease
Summary
A completed switch-over clinical trial evaluating the safety and efficacy of ISU302 in patients with Type 1 Gaucher disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ISU Abxis Co., Ltd. | Conditions: Gaucher Disease | Status: COMPLETED